How Much Does NAD+ Cost Through Telehealth?

Direct answer

Telehealth NAD+ pricing varies by formulation and plan length. RightFit’s current dataset includes compounded injection, nasal-spray, and oral-tablet programs, with ordinary monthly pricing, prepaid discounts, and some separate memberships. The useful comparison is the exact route and formulation plus the standard price, required fees, commitment, and what the provider includes.

Current NAD+ price snapshot

Tracked NAD+ prices by provider and formulation

Injection, nasal spray, and oral pricing belong in separate groups

The current RightFit catalog tracks NAD+ injections, nasal sprays, and an oral tablet as separate compounded formulations. A single “NAD+ average” can therefore mix unlike routes and supply formats unless the data is segmented first.

A lower nasal-spray price is not automatically a cheaper version of an injection program, and an oral tablet price should not be treated as interchangeable with either route.

The current injection market has the most provider competition

Injection programs are the largest route group in the current dataset and span ordinary monthly offers plus several multi-month discounts. Published normal injection prices and promotional equivalents vary because providers use different supply, term, membership, and included-service structures.

Multi-month discounts can materially lower the effective monthly amount

Amble currently publishes one-, three-, six-, and twelve-month NAD+ injection plans, while Belle, Effecty, Gimme Care, Yucca Health, and other providers use their own monthly or multi-month structures. The lower effective amount belongs beside the required term.

RightFit stores multi-month rates as promotional or term-dependent observations instead of replacing the standard monthly price.

The amount due today matters

A twelve-month NAD+ plan can advertise a substantially lower monthly equivalent while requiring a much larger upfront purchase. A shopper comparing affordability should therefore distinguish the effective monthly rate from the cash required at enrollment.

Memberships can change the recurring total

Some tracked NAD+ programs bundle clinical access with the medication price, while others use separate memberships. IViM Health’s current NAD+ record notes a separate membership, and NavioMD publishes a separate subscription fee on its current product page.

Those recurring fees belong outside the medication amount so the source price remains intact while the full program structure stays visible.

Shipping is frequently included

Many current NAD+ provider rows explicitly include shipping. When the provider publishes that inclusion, RightFit records it. When a page is silent, shipping remains unknown rather than assumed free.

Clinical access can be inside the program price

Several current provider prices explicitly include provider evaluation or telehealth access. Others separate a membership or leave the inclusion less clear. A cost comparison should show which model applies rather than assuming every advertised medication amount includes the same care.

FDA compounding context matters for sterile injectable programs

FDA has warned compounders to use ingredients suitable for sterile compounding and specifically described concerns about food-grade NAD+ being used for intravenous compounded products. FDA noted contamination and endotoxin risks when unsuitable ingredients are used without appropriate processing.

That warning does not establish a problem with every provider or pharmacy in RightFit’s dataset. It is a reason to keep compounded status and pharmacy/product sourcing separate from provider wellness marketing and to avoid treating all NAD+ formulations as one standardized product.

Provider wellness claims are not part of the price calculation

Providers may market NAD+ around energy, recovery, aging, performance, or other outcomes. RightFit does not use those claims to justify a higher price or to rank a provider. The cost page compares public commercial facts, not clinical effectiveness.

How to calculate a practical recurring NAD+ cost

Begin with the normal price for the exact formulation and route. Add any verified required membership or subscription for the same period. Note whether shipping and clinical care are included, and keep prepaid monthly equivalents separate from the normal rate.

What to check before enrolling

• Exact formulation and route
• Normal recurring price
• Promotional or multi-month price
• Plan length and amount due up front
• Separate membership or subscription fee
• Whether clinician access and shipping are included
• Supply amount and billing period
• Cancellation and renewal terms
• Program-level state availability if verified
• Source and last-verification date

Why a lower price cannot establish better value medically

A lower NAD+ price does not establish that a particular route or product is clinically preferable, that provider marketing outcomes are proven, or that treatment is appropriate for an individual. Those questions are separate from the public commercial comparison.

Why prices need frequent re-verification

Compounded-program prices can change when providers alter pharmacies, supply sizes, commitments, or included services. A page can still say NAD+ while the actual commercial offer changes. Verification dates make those revisions visible and allow price history to develop over time.

Current provider pages show why route-specific pricing matters

A provider may display several NAD+ formats at different starting amounts on the same page. Shed currently lists injection, nasal-spray, and oral NAD+ options separately, which demonstrates why one headline “NAD+ price” can be misleading. The relevant cost is the price of the exact route and supply being compared, not the provider’s lowest NAD+ number.

Other providers also separate injection and nasal products or publish longer-term discounts. The market therefore contains both route differences and billing-term differences at the same time. RightFit keeps those dimensions separate so a nasal starting price is not used as the cost of an injection and a prepaid effective rate is not presented as an unrestricted monthly price.

Promotions should not replace the standard recurring price

Longevity providers can run first-month discounts, coupon-code offers, affiliate landing pages, or prepaid-plan promotions. Those offers can be useful to a reader, but they are conditional prices. The standard recurring amount remains necessary for understanding what the program may cost after the promotional period or outside the eligibility window.

When RightFit captures a promotion, it should preserve the eligibility language, effective period when available, and the normal price beside it. That prevents an attractive first-month amount from being misread as the long-term cost.

NAD+ totals can be understated when a membership is separate

Some providers advertise a medication amount while charging a separate platform or clinical membership. Others include provider access in the displayed price. A fair cost comparison needs to identify which structure applies before adding or comparing recurring totals.

RightFit stores required program fees separately rather than editing the provider’s medication amount. That preserves the source fact while still allowing a reader to understand that the practical recurring obligation may include more than one charge.

A price table cannot answer the clinical-value question

The fact that one NAD+ route or provider costs less does not establish that it delivers the same exposure, outcomes, safety profile, or suitability as another formulation. Provider pages can make broad wellness claims, but those claims are not part of RightFit’s price calculation and should not be used to justify a cost premium or discount.

The commercial comparison is deliberately narrower: what is sold, in what form, for how much, under what billing terms, with which required fees, and from which current source.

A complete NAD+ cost check should answer these questions

• Which route is being priced: injection, nasal spray, or oral?
• Is the displayed amount the standard recurring price or a promotion?
• Does a lower monthly equivalent require several months of prepayment?
• Is clinician access included or charged through a separate membership?
• Is shipping explicitly included?
• Are labs or other required services published separately?
• Does the provider publish cancellation or renewal terms?
• Is the exact formulation verified for the relevant state?
• How recently was the provider-owned price source checked?

Bottom line

There is no single telehealth NAD+ price. Current programs differ by route, formulation, plan term, membership structure, and inclusions. RightFit keeps those variables separate and uses provider-primary sources for the commercial facts while treating clinical marketing claims and sterile-compounding concerns as separate evidence questions.